News

The novel anti-cancer molecule is expected to go into clinical trials by 2012 and both the companies will continue the collaboration in the development phase as well. Endo

Takeda Pharmaceutical (China) Company in Taizhou is responsible for marketing and sales, and Tianjin Takeda Pharmaceuticals in Tianjin is responsible for manufacturing. Together with Takeda China and Tianjin

As per the agreement, Zalicus will pay Hydra an upfront payment and fund research and development activities at Hydra for a two-year period. Hydra will perform the preclinical

Doxycycline Hyclate DR tablets are the generic version of the company’s Doryx, which is marketed by Warner Chilcott. Mylan CEO Heather Bresch said they are pleased by FDA’s

As per the settlement agreement, the companies have signed a supply agreement whereby Janssen will manufacture and supply Watson with an authorized generic version of ORTHO TRI-CYCLEN LO.

Through the collaboration, the newly launched MRF Translational Medicine Center will determine the myelin regenerating capabilities of proprietary small molecule compounds from Endece Neural. The aim of the

Brachyury is over-expressed in a variety of important tumor types including breast, colon, lung and prostate cancers. The primary endpoint of open-label study is the safety and tolerability

Labco has been offering HPV OncoTect, a cervical cancer test, on a limited basis since 2010. The HPV OncoTect assay quantifies the overexpression of E6/E7 mRNA, the cancer-causing

Under the agreement, ABL will be responsible for the production and characterization of a master virus seed stock, a reservoir of virus produced under strict cGMP conditions. The